Chordia Therapeutics Inc. (TYO:190A)
Japan
· Delayed Price · Currency is JPY 155.00
+4.00 (2.65%)
Apr 28, 2026, 3:30 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 11.43 billion as of April 29, 2026. Its market cap has decreased by -35.31% in one year.
Market Cap
11.43B
Enterprise Value
8.98B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
155.00
Market Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 11.43B, a decrease of -9.19%. That is a compound annual growth rate of -5.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 11.43B | 53.38% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Satudora Holdings | 11.92B |
| Medical System Network | 14.70B |
| Tsubota Laboratory | 7.61B |
| Ohki Healthcare Holdings | 18.57B |
| Astena Holdings | 19.42B |
| Pharmarise Holdings | 5.97B |
| YAKUODO HOLDINGS | 34.12B |
| Heartseed | 41.56B |